Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Tanta University | Conditions: Hepatic and Post Hepatic Jaundice | Phase 2 | Status: COMPLETED